Additionally, we were able to recapitulate monocytic differentiation in AML using gene expression of relevant marker genes (CD34, CD33, or FCGR1A/CD64) whose protein expression characterization was validated with flow cytometry (Fig. 2F; Supplementary Table 3). This evidence concerns the gene FCGR1A and acute myeloid leukemia.